Compare FSCO & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FSCO | SSII |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | FSCO | SSII |
|---|---|---|
| Price | $5.91 | $3.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 709.7K | 104.0K |
| Earning Date | 01-01-0001 | 03-20-2026 |
| Dividend Yield | ★ 11.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $36,066,457.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 158.36 |
| 52 Week Low | $4.08 | $3.02 |
| 52 Week High | $6.00 | $22.42 |
| Indicator | FSCO | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 31.51 | 27.27 |
| Support Level | $5.79 | $4.12 |
| Resistance Level | $6.12 | $6.01 |
| Average True Range (ATR) | 0.11 | 0.53 |
| MACD | -0.05 | -0.18 |
| Stochastic Oscillator | 16.95 | 16.03 |
FS Credit Opportunities Corp is a closed-end management investment company. The Fund's primary investment objective is to generate an attractive total return consisting of a high level of current income and capital appreciation, with a secondary objective of capital preservation. It predominantly invests in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments. The credit instruments in which it invests typically are rated below investment grade by rating agencies or would be rated below investment grade if rated. To achieve its investment objectives, the fund focuses on strategies such as Opportunistic Credit, Special Situations, and Capital Structure Solutions.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.